E
Elizabeth H. Slate
Researcher at Florida State University
Publications - 97
Citations - 7412
Elizabeth H. Slate is an academic researcher from Florida State University. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 28, co-authored 96 publications receiving 7007 citations. Previous affiliations of Elizabeth H. Slate include Cornell University & Medical University of South Carolina.
Papers
More filters
Journal ArticleDOI
Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the Skin: A Randomized Controlled Trial
Larry C. Clark,Gerald F. Combs,Bruce W. Turnbull,Elizabeth H. Slate,Dan K. Chalker,James Chow,Loretta S. Davis,Renee A. Glover,Gloria F. Graham,Earl G. Gross,Arnon Krongrad,Jack L. Lesher,H. Kim Park,Beverly B. Sanders,Cameron L. Smith,J. Richard Taylor +15 more
TL;DR: Results from secondary end-point analyses support the hypothesis that supplemental selenium may reduce the incidence of, and mortality from, carcinomas of several sites and require confirmation in an independent trial of appropriate design before new public health recommendations regarding seenium supplementation can be made.
Journal ArticleDOI
Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial.
Larry C. Clark,Bruce L. Dalkin,Arnon Krongrad,Gerald F. Combs,Bruce W. Turnbull,Elizabeth H. Slate,Roy Witherington,J. H. Herlong,E. Janosko,D. Carpenter,C. Borosso,S. Falk,J. Rounder +12 more
TL;DR: Although selenium shows no protective effects against the primary endpoint of squamous and basal cell carcinomas of the skin, the selenum-treated group had substantial reductions in the incidence of prostate cancer, and total cancer incidence and mortality that demand further evaluation in well-controlled prevention trials.
Journal Article
Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial.
Anna J. Duffield-Lillico,Mary E. Reid,Bruce W. Turnbull,Gerald F. Combs,Elizabeth H. Slate,Lori A. Fischbach,James R. Marshall,Larry C. Clark +7 more
TL;DR: The Nutritional Prevention of Cancer trial continues to show a protective effect of selenium on cancer incidence, although not all site-specific cancers exhibited a reduction in incidence.
Journal ArticleDOI
Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial
Anna J. Duffield-Lillico,Bruce L. Dalkin,Mary E. Reid,Bruce W. Turnbull,Elizabeth H. Slate,Elizabeth T. Jacobs,James R. Marshall,Larry C. Clark +7 more
TL;DR: The results (to January 1996, the end of blinded treatment) of the Nutritional Prevention of Cancer (NPC) Trial, a randomized trial of selenium (200 µg daily) designed to test the hypothesis that seenium supplementation (SS) could reduce the risk of recurrent nonmelanoma skin cancer among 1312 residents of the Eastern USA.
Journal ArticleDOI
Global Validation of Linear Model Assumptions.
Edsel A. Peña,Elizabeth H. Slate +1 more
TL;DR: An easy-to-implement global procedure for testing the four assumptions of the linear model and its performance is compared with three potential competitors, including a procedure based on the Box–Cox power transformation.